Author:
Taniguchi Masahiko,Furukawa Hiroyuki
Reference27 articles.
1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–76. PubMed PMID: 14100514. Pubmed Central PMCID: 2634660. Epub 1963/12/01. eng.
2. Mehrabi A, Fonouni H, Muller SA, Schmidt J. Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg. 2008;393(3):245–60. PubMed PMID: 18309513. Epub 2008/03/01. eng.
3. Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, et al. Combination of extended donor criteria and changes in the model for end-stage liver disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation. 2007;83(5):588–92. PubMed PMID: 17353779. Epub 2007/03/14. eng.
4. Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation. 2006;82(12):1653–7. PubMed PMID: 17198254. Epub 2007/01/02. eng.
5. Furukawa H, Taniguchi M, Fujiyoshi M, Oota M, Japanese Study Group of Liver T. Experience using extended criteria donors in first 100 cases of deceased donor liver transplantation in Japan. Transplant Proc. 2012;44(2):373–5.